We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus.
- Authors
Maggs, David G.; Bauchanan, Thomas A.; Burant, Charles F.; Cline, Gary; Gumbiner, Barry; Hsueh, Willa A.; Inzucchi, Silvio; Kelley, David; Nolan, John; Olefsky, Jerrold M.; Polonsky, Kenneth S.; Silver, David; Valiquett, Thomas R.; Shulman, Gerald I.
- Abstract
Presents a study which investigated how troglitazone, an insulin-sensitizing agent used to treat type 2 diabetes mellitus, affected glucose metabolism in patients. How type 2 diabetes is characterized; Details on the development of thiazolidinediones; How this research was conducted; Suggestion that troglitazone monotherapy decreases fasting and postprandial glucose levels in patients with non-insulin dependent diabetes.
- Subjects
TYPE 2 diabetes treatment
- Publication
Annals of Internal Medicine, 1998, Vol 128, Issue 3, p176
- ISSN
0003-4819
- Publication type
Article
- DOI
10.7326/0003-4819-128-3-199802010-00002